460 related articles for article (PubMed ID: 31622787)
1. In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy.
Liu Y; Liu Q; Liu Y; Ju F; Ma Q; He Q
J Photochem Photobiol B; 2019 Oct; 199():111619. PubMed ID: 31622787
[TBL] [Abstract][Full Text] [Related]
2. Formulation and comparative characterization of nanoparticles of curcumin using natural, synthetic and semi-synthetic polymers for wound healing.
Shende P; Gupta H
Life Sci; 2020 Jul; 253():117588. PubMed ID: 32220621
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
4. The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells.
Sampath M; Pichaimani A; Kumpati P; Sengottuvelan B
Int J Biol Macromol; 2020 Nov; 162():748-761. PubMed ID: 32585267
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
[TBL] [Abstract][Full Text] [Related]
6. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
[TBL] [Abstract][Full Text] [Related]
7.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
8. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis.
Öztürk AA; Namlı İ; Güleç K; Kıyan HT
Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668
[TBL] [Abstract][Full Text] [Related]
9. Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin.
Pandey P; Rahman M; Bhatt PC; Beg S; Paul B; Hafeez A; Al-Abbasi FA; Nadeem MS; Baothman O; Anwar F; Kumar V
Nanomedicine (Lond); 2018 Apr; 13(8):849-870. PubMed ID: 29565220
[TBL] [Abstract][Full Text] [Related]
10. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
[TBL] [Abstract][Full Text] [Related]
11. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
12. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
13. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
14. Versatile Methodology to Encapsulate Gold Nanoparticles in PLGA Nanoparticles Obtained by Nano-Emulsion Templating.
Fornaguera C; Feiner-Gracia N; Dols-Perez A; García-Celma MJ; Solans C
Pharm Res; 2017 May; 34(5):1093-1103. PubMed ID: 28197757
[TBL] [Abstract][Full Text] [Related]
15. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
16. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
17. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells.
Sharma A; Hawthorne S; Jha SK; Jha NK; Kumar D; Girgis S; Goswami VK; Gupta G; Singh S; Dureja H; Chellappan DK; Dua K
Nanomedicine (Lond); 2021 Aug; 16(20):1763-1773. PubMed ID: 34296625
[No Abstract] [Full Text] [Related]
18. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
19. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles.
Mohammad Gholinia Sarpoli L; Zare-Karizi S; Heidari E; Hasanzadeh A; Bayandori M; Azedi F; Hamblin MR; Karimi M
Pharm Dev Technol; 2022 Sep; 27(7):785-793. PubMed ID: 36043390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
